Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3481-3486

  Cakmakoglu, Bedia Agachan ^a   Attar, Rukset ^b   Kahraman, Ozlem Timirci ^a   Dalan, Altay Burak ^a   Iyibozkurt, Ahmet Cem ^c   Karateke, Ates ^d   Attar, Erkut ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Neonatal Intensive Care Unit   (Turkey)

Author keywords

Cox 2; Epithelial ovarian carcinoma; Polymorphism

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; EPITHELIAL OVARY CARCINOMA; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; OVARY CARCINOMA; RISK ASSESSMENT;

ADULT; CYCLOOXYGENASE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 80052513294     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0458-7     Document Type: Article

References (32)

1. Gerd HC, Rikke C, Gerda E, KrÜger KS (2008) Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of fiveyear relative survival in the period 1978-2002. Acta Obstet Gynecol Scand 87(12):1353-1360
2. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519-2529
3. Hamberg M, Samuelsson B (1973) Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70:899-903
4. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073 (Pubitemid 28418937)
5. Hoff J, Morsche HM, Roelofs HMJ, Van der Logt EMJ, Nagengast FM, Peters WHM (2009) COX-2 polymorphisms -765G→ C and -1195A→ G and colorectal cancer risk. World J Gastroenterol 15(36):4561-4565
6. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188 (Pubitemid 24294584)
7. Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455-460 (Pubitemid 28160637)
8. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58:4997-5001 (Pubitemid 28521147)
9. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198-204 (Pubitemid 29062978)
10. Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H (1999) Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 46:407-412 (Pubitemid 29154786)
11. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7305-7309 (Pubitemid 32946529)
12. Ozel E, Pestereli HE, Simsek T, Erdogan G, Karaveli FS (2006) Expression of cyclooxygenase- 2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters? Int J Gynecol Cancer 16:549-555
13. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T (1994) Characterization of the human gene (PTGS2) encoding prostaglandin- endoperoxide synthase 2. Eur J Biochem 221:889-897 (Pubitemid 24146188)
14. Harrison JR, Lorenzo JA, Kawaguchi H, Raisz LG, Pilbeam C (1994) Stimulation of prostaglandin E2 production by interleukin- 1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells. J Bone Miner Res 9:817-823 (Pubitemid 24178064)
15. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19:723-729 (Pubitemid 28376760)
16. Ohno S, Ohno Y, Suzuki N, Inagawa H, Kohchi C, Soma G, Inoue M (2005) Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res 25:3679-3687 (Pubitemid 41658439)
17. Young JL, Jazaeri AA, Darus CJ, Modesitt SC (2008) Cyclooxygenase- 2 in cervical neoplasia: a review. Gynecol Oncol 109:140-145
18. Miller SA, Dykes DD, Polesky HS (1988) Simples salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16(3):1215
19. Shi J, Misso NL, Duffy DL, Thompson PJ, Kedda MA (2004) A functional polymorphism in the promoter region of the cyclooxygenase- 2 gene is not associated with asthma and atopy in an Australian population. Clin Exp Allergy 34(11):1714-1718 (Pubitemid 39551524)
20. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129:565-576 (Pubitemid 41096644)
21. Tan W, Wu J, Zhang X, Guo Y, Liu J, Sun T, Zhang B, Zhao D, Yang M, Yu D, Lin D (2007) Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12 lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 28:1197-1201 (Pubitemid 47064309)
22. Koh WP, Yuan JM, van den Berg D, Lee HP, Yu MC (2004) Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese health study. Br J Cancer 90:1760-1764 (Pubitemid 38725648)
23. Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J (2005) PTGS2 (COX-2) -765G>C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 14:616-619 (Pubitemid 40489204)
24. Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T (1999) Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5:1001-1005 (Pubitemid 29233213)
25. Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M (1999) Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res 90:1338-1343 (Pubitemid 30032072)
26. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, Dong C, Shen L, Li J, Deng D, Lin D, You W (2006) Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130:1975-1984 (Pubitemid 43816953)
27. Ben Nasr H, Chahed K, Bouaouina N, Chouchane L (2009) PTGS2 (COX-2) -765 G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 36(1):193-200
28. Zhu W, Wei BB, Shan X, Liu P (2010) 2765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies. Mol Biol Rep 37:277-288
29. Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG (2007) COX-2 CA haplotype is a risk factor for the development of esophageal adenocarcinoma. Am J Gastroenterol 102:2373-2379 (Pubitemid 47631756)
30. Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Hölscher AH, Danenberg KD, Danenberg PV (2002) Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg 235(3):440-3. (Pubitemid 34183896)
31. Erratum in: Ann Surg 235(6):896-7
32. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of nonsmall cell lung carcinoma. Clin Cancer Res 6(12):4739-4744 (Pubitemid 32110413)